Joint Health

Millions of people, and especially those with aging joints, are looking for products that can help them keep moving in order to enjoy a good quality of life.

Marine Omega-3 fatty acids have been shown to provide nutritional support to help keep the cartilage between the joints healthy. More specifically, it is the fatty acid EPA that has been clinically proven to help maintain day-to-day mobility. EPA supplementation was found especially beneficial for those people with morning joint stiffness.

A formula based on numerous clinical trials,
EPAX 4510 TG has been designed to deliver high levels of concentrated EPA in order to provide nutrition to joints, help reduce stiffness, and support mobility.


 Click here to see articles about Omega-3 and Joint Health
 
 

EPAX 4510 TG

390 mg/g EPA
70 mg/g DHA

EPAX 4510 TG Specification
EPAX 4510 TG Nutritional values
 
 
EPAX News & Events

Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map    •    Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com